Financhill
Sell
40

MNTL Quote, Financials, Valuation and Earnings

Last price:
$24.67
Seasonality move :
--
Day range:
$24.67 - $24.67
52-week range:
$23.67 - $27.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
--
Revenue:
--
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Tema Neuroscience and Mental Health ETF has -- downside to fair value with a price target of -- per share.

MNTL vs. S&P 500

  • Over the past 5 trading days, Tema Neuroscience and Mental Health ETF has overperformed the S&P 500 by 2.84% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Tema Neuroscience and Mental Health ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Tema Neuroscience and Mental Health ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Tema Neuroscience and Mental Health ETF reported revenues of --.

Earnings Growth

  • Tema Neuroscience and Mental Health ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Tema Neuroscience and Mental Health ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-01-12 2024-01-12 2024-01-12
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2021-01-12 2022-01-12 2023-01-12 2024-01-12
Balance Sheet
Current Assets -- -- -- -- --
Total Assets -- -- -- -- --
Current Liabilities -- -- -- -- --
Total Liabilities -- -- -- -- --
Total Equity -- -- -- -- --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-01-12 2024-01-12 2024-01-12
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
MNTL
Sector
Market Cap
--
--
Price % of 52-Week High
89.18%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
--
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $24.55
200-day SMA
Sell
Level $25.84
Bollinger Bands (100)
Sell
Level 25.28 - 27.22
Chaikin Money Flow
Sell
Level -49.9K
20-day SMA
Sell
Level $24.87
Relative Strength Index (RSI14)
Sell
Level 40.46
ADX Line
Buy
Level 15.3
Williams %R
Neutral
Level -37.2154
50-day SMA
Sell
Level $25.65
MACD (12, 26)
Sell
Level -0.33
25-day Aroon Oscillator
Sell
Level -40
On Balance Volume
Sell
Level -156.1K

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
--
Momentum Score
Level (--)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Stock Forecast FAQ

In the current month, MNTL has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MNTL average analyst price target in the past 3 months is --.

  • Where Will Tema Neuroscience and Mental Health ETF Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Tema Neuroscience and Mental Health ETF share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Tema Neuroscience and Mental Health ETF?

    Analysts are divided on their view about Tema Neuroscience and Mental Health ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Tema Neuroscience and Mental Health ETF is a Sell and believe this share price will rise from its current level to --.

  • What Is Tema Neuroscience and Mental Health ETF's Price Target?

    The price target for Tema Neuroscience and Mental Health ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is MNTL A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Tema Neuroscience and Mental Health ETF is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of MNTL?

    You can purchase shares of Tema Neuroscience and Mental Health ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Tema Neuroscience and Mental Health ETF shares.

  • What Is The Tema Neuroscience and Mental Health ETF Share Price Today?

    Tema Neuroscience and Mental Health ETF was last trading at $24.67 per share. This represents the most recent stock quote for Tema Neuroscience and Mental Health ETF. Yesterday, Tema Neuroscience and Mental Health ETF closed at $24.67 per share.

  • How To Buy Tema Neuroscience and Mental Health ETF Stock Online?

    In order to purchase Tema Neuroscience and Mental Health ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is American Tower Stock Undervalued?
Is American Tower Stock Undervalued?

The market action of late has been nothing short of…

Is Broadcom Stock Overvalued?
Is Broadcom Stock Overvalued?

The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…

4 Top Dividend Stocks to Buy Now
4 Top Dividend Stocks to Buy Now

If you’re looking for steady income, dividend stocks are a…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock